News for LivaNova PLC (LIA.F)

Mailing Address 20 EASTBOURNE TERRACE LONDON X0 W2 6LG Business Address 20 EASTBOURNE TERRACE LONDON X0 W2 6LG 4402033250662 CIK : 0001639691 (see all company...

The following slide deck was published by LivaNova PLC in conjunction with their 2020 Q4 earnings call.

LivaNova PLC (LIVN): Q4 Non-GAAP EPS of $0.71 beats by $0.03; GAAP EPS of -$5.74 misses by $4.49.Revenue of $269.6M (-6.3% Y/Y) beats by $0.77M.2021 Guidance:LivaNova expects worldwide...

/PRNewswire/ -- The global deep brain stimulation devices market size is anticipated to reach USD 2.3 billion by 2028, according to a new report by Grand View...

SAN FRANCISCO, Feb. 22, 2021 /PRNewswire/ -- The global deep brain stimulation devices market size is anticipated to reach USD 2.3 billion by 2028...

DUBLIN, Feb. 4, 2021 /PRNewswire/ -- The 'Cardiac Monitoring & Cardiac Rhythm Management - Global Market Outlook (2019-2027)' report has been adde...

LONDON — Vivid Sehgal has been named chief financial officer for Tate & Lyle PLC, effective May 1. He will join the company and the board of directors on March 1. Most recently, Mr. Sehgal was CFO for Delphi Technologies PLC, a role he held for three years. Before that, he was CFO for LivaNova PLC for two years. Previously, Mr. Sehgal was senior vice president of treasury, risk and investor relations at Allergan Inc., and prior to that was regional finance director of the . . .

Los Angeles, USA, Jan. 18, 2021 (GLOBE NEWSWIRE) -- Implantable Cardiac Monitors Market Expected To Rise By A CAGR Of 4.4% By 2025 The steady growth of the ...

Pune, India, Jan. 13, 2021 (GLOBE NEWSWIRE) -- The global autotransfusion devices market is set to gain traction from the increasing adoption of cell ...